Wolverine Trading’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.64M Buy
120,300
+79,700
+196% +$1.78M ﹤0.01% 1935
2025
Q2
$891K Buy
40,600
+5,400
+15% +$120K ﹤0.01% 2423
2025
Q1
$843K Buy
35,200
+4,100
+13% +$97K ﹤0.01% 2411
2024
Q4
$640K Sell
31,100
-800
-3% -$21K ﹤0.01% 3114
2024
Q3
$1.02M Buy
+31,900
New +$942K ﹤0.01% 2336
2021
Q4
Sell
-22,300
Closed -$944K 6726
2021
Q3
$944K Sell
22,300
-500
-2% -$25.5K ﹤0.01% 3064
2021
Q2
$1.5M Sell
22,800
-900
-4% -$48.9K ﹤0.01% 2295
2021
Q1
$1.03M Buy
+23,700
New +$880K ﹤0.01% 2718
2018
Q4
Sell
-16,000
Closed -$264K 5254
2018
Q3
$264K Buy
+16,000
New +$255K ﹤0.01% 3901

Other funds holding SGRY

Wolverine Trading's SGRY Position: Q3 2025 in Review

Wolverine Trading reduced its Surgery Partners (SGRY) stake by 70% in Q3 2025, selling an estimated $546K and leaving 10,726 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #4721.

Wolverine Trading first reported a position in SGRY in Q3 2018 and has held it in 6 quarters since. The position peaked at $772K in Q2 2025. 199 funds tracked by Wall St. Rank hold SGRY as of Q3 2025.

  • Wolverine Trading held 10,726 shares of Surgery Partners worth $235K as of Q3 2025.
  • Wolverine Trading sold 24,462 Surgery Partners shares in Q3 2025, an estimated $546K.
  • Surgery Partners made up ﹤0.01% of Wolverine Trading's portfolio in Q3 2025, its #4721 holding.
  • Wolverine Trading first reported a position in Surgery Partners in Q3 2018 and has held it in 6 quarters since.
  • Wolverine Trading's Surgery Partners position peaked at $772K in Q2 2025.
  • 199 funds tracked by Wall St. Rank held Surgery Partners as of Q3 2025.

Based on Wolverine Trading's 13F filing for Q3 2025, filed 14 Nov 2025.